<DOC>
	<DOCNO>NCT00220909</DOCNO>
	<brief_summary>The primary objective study determine whether lansoprazole , administer intravenously , protect patient undergoing cardiac surgery development and/or progression previously undetected acid/peptic disorder ( erosive esophagitis , gastric ulcer , duodenal ulcer , diffuse gastritis , duodenitis ) measure Lanza score LA classification esophageal injury . The secondary objective study : 1 . To determine intravenous lansoprazole protects development clinically important gastrointestinal bleeding population ( overt bleed require blood transfusion ) . 2 . To determine intravenous lansoprazole maintains intragastric pH placebo throughout study period .</brief_summary>
	<brief_title>Lansoprazole Preventing Gastroduodenal Stress Ulcerations</brief_title>
	<detailed_description>This randomize , double-blind single center study compare efficacy lansoprazole IV infusion daily ( 60 mg bolus follow 6 mg per hour ) compare ranitidine 50 mg IV q12 h heal pre-existing prevent perioperative stress ulcer associate upper GI bleeding . Patients undergo complete history include medication history intake ASA/NSAIDs/anticoagulants/antiplatelet agent , physical examination , complete blood count , complete metabolic profile , ECG 's chest x-rays rule exclusionary illness . Female subject urine pregnancy test perform . They sign inform consent participate randomize , double-blind study protocol . Patients exclude currently use acid suppressive therapy history gastric/duodenal ulcer gastroesophageal reflux disease require acid suppressive therapy . Patients randomize receive either lansoprazole ranitidine intravenously continuous intravenous infusion morning surgery subsequent 4 day . Computer randomization use code keep pharmacy . The allocation conceal . Medication deliver seal , unlabeled container pharmacy . Patients stratify placebo lansoprazole preceding ASA/NSAID use . Lansoprazole give 60 mg bolus preoperatively follow 6 mg per hour throughout duration study . At time airway intubation operate room surgery , nasogastric tube built-in intragastric pH electrode ( Zinetics , Inc ) pass mid-stomach anesthesiologist place standard nasogastric tube . Intragastric pH measure perisurgical period morning postoperative day 4 , 72 hour surgery . At time , nasogastric tube/pH probe remove patient undergo esophagogastroduodenoscopy ( EGD ) sedation midazolam fentanyl . During endoscopy , maximum number submucosal hemorrhage erosion endoscopic field anterior posterior wall antrum count . Modified Lanza score stomach duodenum determine quantify gastric duodenal erosion ulcerations6 . We also determine LA classification esophageal injury inflammation . Before removal endoscope , wireless pH capsule ( Bravo pH capsule ; Medtronic , Inc ) place body stomach 12 cm squamocolumnar junction additional two day measurement intragastric pH time discharge hospital le 48 hour EGD . Thus , intragastric pH monitor morning patient undergoes surgery 6 day time discharge . After completion surgery , patient follow hemoglobin hematocrit every 12 hour ; stool test blood qualitatively ( Hemoccult ) quantitatively ( Hemaquant ) . Postoperatively , hemoglobin level maintain 10 gm % use pack red blood cell transfusion need . Transfusion requirement quantify . The time patient resume oral intake note along specific data oral liquid solid food composition .</detailed_description>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>Patients symptomatic coronary artery disease valvular heart disease require corrective cardiac surgery eligible participate study . Patients undergo cardiovascular surgery , specifically elective coronary artery bypass graft cardiac valve replacement surgery , Temple University Hospital Able provide inform consent Evidence active gastrointestinal bleeding Prior gastric ( e.g . Billroth II ) esophageal surgery Pregnancy Preexisting current condition require acidsuppressive therapy e.g . reflux esophagitis , gastric duodenal ulcer Current use acidsuppressive therapy , proton pump inhibitor histamine type 2 receptor antagonist Contraindication naso orogastric intubation ( e.g . Zenker 's diverticulum , esophageal stricture ) Bleeding diathesis Allergy lansoprazole Advanced renal disease ( BUN &gt; 40 and/or creatinine &gt; 2.0 . Advanced liver disease ( Alkaline phosphatase , ALT , AST &gt; 2 x normal )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Gastric erosion</keyword>
	<keyword>Proton pump inhibitor</keyword>
</DOC>